Europe — EMA
Paclitaxel Ebewe
Paclitaxel, the active ingredient in Paclitaxel Ebewe, is a mitotic inhibitor presented as a sterile powder for intravenous infusion use. It treats various solid tumours and is administered in oncology patients.
Request sourcing
What is Paclitaxel?
Paclitaxel, the active ingredient in Paclitaxel Ebewe, is a mitotic inhibitor presented as a sterile powder for intravenous infusion use. It treats various solid tumours and is administered in oncology patients. GNH USA supplies Paclitaxel Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.
GNH USA supplies Paclitaxel Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres through global distribution.
What is Paclitaxel used for?
Paclitaxel is an antineoplastic agent that interferes :
- Breast Cancer: Stabilizes the microtubule network and prevents cell division in tumour cells. - Ovarian Cancer and Fallopian tube approved t t t. - . - . - . - .
What are the side effects of Paclitaxel?
....
What precautions apply to Paclitaxel?
....
What does Paclitaxel interact with?
...
Product details
Related products
Paclitaxel 100 mg/20mL
Paclitaxel · 100 mg/20 mL
PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND 100 mg/20mL
Paclitaxel · 100 mg/20 mL
Paclitaxel 6 mg/mL
Paclitaxel · 6 mg/mL
Paclitaxel 6 mg/mL
Paclitaxel · 6 mg/mL